SCHEMBL21032312

SCHEMBL21032312

Cc1cc(-c2ccc3oc4cccnc4c3c2)cc(-c2ccc3oc4cccnc4c3c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK9 P50750 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ DYRK2 Q92630 1/20 0.39
▸ PDE4D Q08499 2/20 0.36
▸ PSMD14 O00487 1/20 0.36
▸ COPS5 Q92905 1/20 0.36
▸ NPC1 O15118 5/20 0.36
▸ L3MBTL1 Q9Y468 4/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ MAPT P10636 3/20 0.35
▸ COMT P21964 1/20 0.35
▸ MAPK14 Q16539 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ATM Q13315 2/20 0.35
▸ MAP4K4 O95819 1/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16482065 0.92 NPC1 (0.40) CDK9DYRK1ADYRK2PDE4DNPC1
SCHEMBL15855412 0.92 NPC1 (0.42) CDK9DYRK1ADYRK2PDE4DNPC1
SCHEMBL15836114 0.91 NPC1 (0.42) CDK9DYRK1ADYRK2PDE4DNPC1
SCHEMBL15855411 0.90 MAPK14 (0.35) CDK9DYRK1ADYRK2PDE4DNPC1
SCHEMBL15695201 0.90 MAP4K4 (0.46) NPC1L3MBTL1HSP90AA1MAPTMEN1
SCHEMBL15317426 0.88 PLA2G2A (0.42) PDE4DNPC1L3MBTL1MAPTMAPK14
SCHEMBL15855202 0.88 PLA2G2A (0.42) PDE4DNPC1L3MBTL1MAPTMAPK14
SCHEMBL15855200 0.88 PLA2G2A (0.42) PDE4DNPC1L3MBTL1MAPTMAPK14
SCHEMBL16482063 0.88 NPC1 (0.44) CDK9DYRK1ADYRK2PDE4DNPC1
SCHEMBL15835963 0.88 NPC1 (0.44) CDK9DYRK1ADYRK2PDE4DNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 CDK9 4126/4885DYRK1A 3876/4885DYRK2 3619/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 CDK9 4126/4885DYRK1A 3876/4885DYRK2 3619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback